Navigation Links
Steroid After Tonsillectomy Raises Bleeding Risk
Date:12/9/2008

But dexamethasone did limit vomiting and results are preliminary, researchers note

TUESDAY, Dec. 9 (HealthDay News) -- Children who were given the steroid dexamethasone after a tonsillectomy had less nausea and vomiting, but they also faced an increased risk of bleeding that was significant enough to end the trial early for safety reasons, a new study shows.

"The clinical implication is that children undergoing [tonsillectomy] should not receive dexamethasone prophylactically unless an adequately designed, valid study has shown that our findings can be refuted," said senior study author Dr. Martin R. Tramer, head of anesthesiology at Geneva University Hospitals in Switzerland.

Those taking the highest dose of dexamethasone had about seven times the risk of bleeding, the researchers reported.

The findings appear in the Dec. 10 issue of the Journal of the American Medical Association.

But the Swiss study authors and other experts added that the results are preliminary.

The findings are also at odds with what physicians in the United States see in their own practices.

"I have been practicing for the past 20 years, and I do anywhere from 500 to 1,000 tonsillectomies a year. I give around 0.4 mg/kg [of dexamethasone], and I have many colleagues that do the same, and I have not experienced or seen this kind of bleeding," said Dr. Ramzi Younis, chief of pediatric otolaryngology at the University of Miami School of Medicine.

"This data is too early to change our practice," added Dr. Dean Kurth, director of anesthesia at Cincinnati Children's Hospital, who also noted that medication practices differ between Europe and the United States.

According to background information in the study, almost 190,000 tonsillectomies are performed on children in the United States each year.

Children will commonly feel postoperative nausea and vomiting (PONV) in addition to pain and bleeding after the procedure, which is often done on an outpatient basis.

Non-steroidal anti-inflammatory drugs (NSAIDS) have been used for pain relief but do increase risk of bleeding.

Despite clear information on dosing and side effects, the authors reported, dexamethasone is standard practice at many institutions.

In this trial, 215 children having elective tonsillectomies at a major teaching hospital in Switzerland were randomized to receive 0.05 milligrams per kilogram of dexamethasone, 0.15 mg/kg, 0.5 mg/kg, or a placebo.

They were also given acetaminophen-codeine and ibuprofen (an NSAID) to relieve pain after surgery, and were tracked for 10 days.

The higher the dose of dexamethasone, the less nausea and vomiting the patients experienced. Children receiving the steroid also needed less ibuprofen.

After 24 hours, 44 percent of those taking a placebo had had postoperative nausea and vomiting, compared with 38 percent of those taking 0.05 mg of dexamethasone, 24 percent of those taking 0.15 mg, and 12 percent of those taking 0.5 mg/kg.

But 4 percent of children in the placebo group and in the 0.15 mg/kg dexamethasone group experienced postoperative bleeding, compared to 11 percent of those taking the lowest dose of dexamethasone and 24 percent of those taking the highest dose. Half of those experiencing bleeding needed further surgery.

About a 4 percent bleeding rate is more typical in the United States, Kurth said, and about 10 percent of those cases involve further surgery.

Also, Younis said, in contrast to the European investigators on this trial, he and his colleagues counsel parents not to give NSAIDs to patients, as they can cause bleeding.

One puzzling aspect of the findings is that the lower and higher doses of dexamethasone had higher levels of bleeding than the middle dose.

"They discuss at length the fact that [some of] these findings are surprising and we don't have a good explanation for them," Kurth said.

Bleeding is of particular concern after tonsillectomies because the wound is not sewn up or covered and is exposed to food, air and saliva. A large blood supply courses through the area and, if hemorrhaging does occur, manual compression is next to impossible. That means surgery becomes the only option.

"Our main hypothesis is that the increased bleeding risk with dexamethasone is due to impairment of wound healing. There is a biological basis to support this view," Tramer said.

But until various questions are cleared up through further studies, Kurth said, "If I'm the parent, I would want to know what is the bleeding rate for the particular institution that you're going to."

More information

The U.S. National Library of Medicine has more on tonsillectomies.



SOURCES: Martin R. Tramer, M.D., head, anesthesiology, Geneva University Hospitals, Switzerland; Dean Kurth, M.D., director, anesthesia, and anesthesiologist-in-chief, Cincinnati Children's Hospital, and professor, anesthesiology and pediatrics, University of Cincinnati College of Medicine; Ramzi Younis, M.D., professor, ENT and pediatrics, and chief, pediatric otolaryngology, University of Miami Miller School of Medicine; Dec. 10, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Steroids Seem Safe for Babies at Risk of Early Birth
2. Batters may achieve dramatic increases in home runs through steroids
3. Repeat steroids to premature infants linked to cerebral palsy
4. Multiple corticosteroid injections in pregnant women may increase cerebral palsy
5. International Law Enforcement Operation Targets Underground Manufacture of Anabolic Steroids
6. Steroids Are Abused for Skin, Not Just Muscles
7. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
8. Steroid Fails to Ease Meningitis in Trials
9. Report Finds Widespread Steroid Use in Baseball
10. Pelosi Statement on Mitchell Report on Steroid Use in Baseball
11. Youth Impacted By Recent Mitchell Report on Major League Baseball Steroid Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Steroid After Tonsillectomy Raises Bleeding Risk
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: